Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger R Reddel

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Environmental Health Perspectives|February 3, 2025
IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic HazardsDavid M DeMarini, William Gwinn, Emily Watkins, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Nature|December 23, 2024
Author Correction: π-HuB: the proteomic navigator of the human bodyFuchu He, Ruedi Aebersold, Mark S Baker, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Nature|December 11, 2024
π-HuB: the proteomic navigator of the human bodyFuchu He, Ruedi Aebersold, Mark S Baker, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Environmental Health Perspectives|February 3, 2025
IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic HazardsDavid M DeMarini, William Gwinn, Emily Watkins, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Nature|December 23, 2024
Author Correction: π-HuB: the proteomic navigator of the human bodyFuchu He, Ruedi Aebersold, Mark S Baker, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Nature|December 11, 2024
π-HuB: the proteomic navigator of the human bodyFuchu He, Ruedi Aebersold, Mark S Baker, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 15